David Cavalla

Person

Cambridge, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Dibenzothiazepine derivatives and their use in the treatment of CNS...
- Patent number 9,487,492
- Issue date Nov 8, 2016
- NUMEDICUS LIMITED
- David Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cachexia
- Patent number 8,716,325
- Issue date May 6, 2014
- PsiOxus Therapeutics Limited
- David Cavalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidin...
- Patent number 7,470,690
- Issue date Dec 30, 2008
- Dynogen Pharmaceuticals, Inc.
- David Cavalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of 4-(2-Flurophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-D)-py...
- Patent number 7,220,748
- Issue date May 22, 2007
- Arachnova Therapeutics Ltd.
- David Cavalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aryl isoguanines
- Patent number 6,440,979
- Issue date Aug 27, 2002
- Euro-Celtique, S.A.
- David Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine derivatives having phosphodiesterase iv inhibition activity
- Patent number 6,413,975
- Issue date Jul 2, 2002
- Euro-Celtique, S.A.
- Mark Chasin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzoxazoles
- Patent number 6,372,770
- Issue date Apr 16, 2002
- Euro-Celtique, S.A.
- Mark Chasin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6,5-fused aromatic ring systems having enhanced phosphodiesterase I...
- Patent number 6,365,606
- Issue date Apr 2, 2002
- Euro-Celtique, S.A.
- David Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine derivatives having phosphodiesterase IV inhibition activity
- Patent number 6,319,928
- Issue date Nov 20, 2001
- Euro-Celtique, S.A.
- Mark Chasin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hypoxathine compounds
- Patent number 6,310,205
- Issue date Oct 30, 2001
- Euro-Celtique, S.A.
- Mark Chasin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine derivatives having phosphodiesterase IV inhibition activity
- Patent number 6,294,541
- Issue date Sep 25, 2001
- Euro-Celtique S.A.
- David J. Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Trisubstituted thioxanthines
- Patent number 6,268,373
- Issue date Jul 31, 2001
- Euro-Celtique S.A.
- David Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-(arylalkyl) xanthines
- Patent number 6,248,746
- Issue date Jun 19, 2001
- Euro-Celtique S.A.
- Mark Chasin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phenyl-triazole compounds for PDE-IV inhibition
- Patent number 6,248,769
- Issue date Jun 19, 2001
- Euro-Celtique S.A.
- David John Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine derivatives having phosphodiesterase IV inhibition activity
- Patent number 6,228,859
- Issue date May 8, 2001
- Euro-Celtique S.A.
- David J. Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of Synthesing Purine Compounds Having PDE Iv Inhibitory Act...
- Patent number 6,211,367
- Issue date Apr 3, 2001
- Euro-Celtique, S.A.
- David J. Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors f...
- Patent number 6,166,041
- Issue date Dec 26, 2000
- Euro-Celtique, S.A.
- David J. Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phenylpyridyl compounds for inhibiting phosphodiesterase IV and met...
- Patent number 6,153,630
- Issue date Nov 28, 2000
- Euro-Celtique, S.A.
- David J. Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl imidazole compounds having phosphodiesterase IV inhibitory act...
- Patent number 6,103,749
- Issue date Aug 15, 2000
- Euro-Celtique S.A.
- David John Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl thioxanthines
- Patent number 6,090,816
- Issue date Jul 18, 2000
- Euro-Celtique S.A.
- David John Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6,5-fused aromatic ring systems having enhanced phosphodiesterase I...
- Patent number 6,075,016
- Issue date Jun 13, 2000
- Euro-Celtique S.A.
- Mark Chasin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl thioxanthines
- Patent number 6,066,641
- Issue date May 23, 2000
- Euro-Celtique S.A.
- David Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine compounds having PDE IV inhibitory activity and methods of s...
- Patent number 6,057,445
- Issue date May 2, 2000
- Euro-Celtique S.A.
- David J. Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine compounds having PDE IV inhibitory activity and methods of s...
- Patent number 6,040,447
- Issue date Mar 21, 2000
- Euro-Celtique S.A.
- David J. Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine compounds having PDE IV inhibitory activity and methods of s...
- Patent number 6,037,470
- Issue date Mar 14, 2000
- Euro-Celtique S.A.
- David J. Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Trisubstituted thioxanthines
- Patent number 6,025,361
- Issue date Feb 15, 2000
- Euro-Celtique, S.A.
- David Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Trisubstituted thioxanthines
- Patent number 5,977,119
- Issue date Nov 2, 1999
- Euro-Celtique, S.A.
- David John Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds having PDE-IV inhibition activity
- Patent number 5,939,422
- Issue date Aug 17, 1999
- Euro-Celtique, S.A.
- David Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl pyrazole compound for inhibiting phosphodiesterase IV and meth...
- Patent number 5,922,751
- Issue date Jul 13, 1999
- Euro-Celtique, S.A.
- David John Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds for inhibiting phosphodiesterase IV
- Patent number 5,889,014
- Issue date Mar 30, 1999
- Euro-Celtique, S.A.
- David John Cavalla
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TRICYCLIC DIBENZOTHIAZEPINE TYPE COMPOUNDS FOR USE IN THE THERAPY O...
- Publication number 20190381065
- Publication date Dec 19, 2019
- Healx Limited
- David Cavalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC DIBENZOTHIAZEPINE TYPE COMPOUNDS FOR USE IN THE THERAPY O...
- Publication number 20180271876
- Publication date Sep 27, 2018
- Healx Limited
- David Cavalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIBENZOTHIAZEPINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS...
- Publication number 20140243317
- Publication date Aug 28, 2014
- Numedicus Limited
- David Cavalla
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CACHEXIA
- Publication number 20100292270
- Publication date Nov 18, 2010
- David Cavalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW THERAPEUTIC USE OF 4-(2-FLUOROPHENYL)-6-METHYL-2-(1-PIPERAZINYL...
- Publication number 20090215791
- Publication date Aug 27, 2009
- Dynogen Pharmaceuticals, Inc.
- Hazel Judith Bardsley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazin...
- Publication number 20060167005
- Publication date Jul 27, 2006
- David Cavalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Topical formulation and use of buspirone
- Publication number 20060088556
- Publication date Apr 27, 2006
- David Cavalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of ppar activators for the treatment of pulmonary fibrosis
- Publication number 20060013775
- Publication date Jan 19, 2006
- Robert William Gristwood
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d)pyrimidin...
- Publication number 20050239792
- Publication date Oct 27, 2005
- David Cavalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of 4-(2-flurophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-d)-py...
- Publication number 20050222162
- Publication date Oct 6, 2005
- David Cavalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Arylazo-substituted imidazole for the treatment of stress urinary i...
- Publication number 20040242547
- Publication date Dec 2, 2004
- Robert William Gristwood
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of scarring and related conditions using ppar-gamma activ...
- Publication number 20040152746
- Publication date Aug 5, 2004
- Hazel Judith Bardsley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl...
- Publication number 20040048874
- Publication date Mar 11, 2004
- Hazel Judith Bardsley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Purine compounds having PDE IV inhibitory activity and methods of s...
- Publication number 20030073834
- Publication date Apr 17, 2003
- David J. Cavalla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

David Cavalla

Person

Patents Grantslast 30 patents

Dibenzothiazepine derivatives and their use in the treatment of CNS...

Treatment of cachexia

4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidin...

Use of 4-(2-Flurophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-D)-py...

Aryl isoguanines

Purine derivatives having phosphodiesterase iv inhibition activity

Benzoxazoles

6,5-fused aromatic ring systems having enhanced phosphodiesterase I...

Purine derivatives having phosphodiesterase IV inhibition activity

Hypoxathine compounds

Purine derivatives having phosphodiesterase IV inhibition activity

Trisubstituted thioxanthines

3-(arylalkyl) xanthines

Phenyl-triazole compounds for PDE-IV inhibition

Purine derivatives having phosphodiesterase IV inhibition activity

Methods of Synthesing Purine Compounds Having PDE Iv Inhibitory Act...

2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors f...

Phenylpyridyl compounds for inhibiting phosphodiesterase IV and met...

Aryl imidazole compounds having phosphodiesterase IV inhibitory act...

Aryl thioxanthines

6,5-fused aromatic ring systems having enhanced phosphodiesterase I...

Aryl thioxanthines

Purine compounds having PDE IV inhibitory activity and methods of s...

Purine compounds having PDE IV inhibitory activity and methods of s...

Purine compounds having PDE IV inhibitory activity and methods of s...

Trisubstituted thioxanthines

Trisubstituted thioxanthines

Chemical compounds having PDE-IV inhibition activity

Aryl pyrazole compound for inhibiting phosphodiesterase IV and meth...

Heterocyclic compounds for inhibiting phosphodiesterase IV

Patents Applicationslast 30 patents

TRICYCLIC DIBENZOTHIAZEPINE TYPE COMPOUNDS FOR USE IN THE THERAPY O...

TRICYCLIC DIBENZOTHIAZEPINE TYPE COMPOUNDS FOR USE IN THE THERAPY O...

DIBENZOTHIAZEPINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS...

TREATMENT OF CACHEXIA

NEW THERAPEUTIC USE OF 4-(2-FLUOROPHENYL)-6-METHYL-2-(1-PIPERAZINYL...

New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazin...

Topical formulation and use of buspirone

Use of ppar activators for the treatment of pulmonary fibrosis

4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d)pyrimidin...

Use of 4-(2-flurophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-d)-py...

Arylazo-substituted imidazole for the treatment of stress urinary i...

Treatment of scarring and related conditions using ppar-gamma activ...

New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl...

Purine compounds having PDE IV inhibitory activity and methods of s...